Asia HealthTech Investment Landscape H1 2019 Report
Asia Pac HealthTech ecosystem momentum continues unabated closing at the mid year point at US$2.5B invested, building on the back of a record breaking 2018.
Early stage ventures deal activity shrinks yet further, whereas total Series B and C deal value continues to grow, grabbing 69% of total funding, raising questions regarding the sustainability of the deal flow of Growth stage investors.
This report is powered by HealthTech Alpha, a Galen Growth Asia solution, the only analytics and database platform dedicated to HealthTech in Asia Pac.
